Drugs in R&D

How long-acting risperidone works in the body and its treatment benefits from combining a newer antipsychotic with a new delivery method

Updated

Abstract

Long-acting risperidone can be administered once every 2 weeks, providing sustained therapeutic plasma levels.

  • Long-acting antipsychotic preparations are associated with improved compliance and relapse prevention compared to oral agents.
  • Partial or non-compliance remains a significant issue with oral atypical antipsychotic agents.
  • The long-acting formulation of risperidone may enhance symptom control and quality of life for patients already stable on other treatments.
  • The use of microsphere technology in drug delivery supports sustained medication levels in the bloodstream.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free